PreClinical CRO dedicated to your NonClinical projects
WELCOME
PreClinical CRO dedicated to your non clinical projects
Welcome on the new website of your provider of non clinical drug evaluation services.
As you will find during your visit on our website, Syncrosome is one of the rare companies able to conduct efficacy, safety and pharmacokinetic studies to give you a complete in vivo overview of your research projects.
Syncrosome offers you professional non-clinical drug evaluation in the pre-clinical phase, supported by considerable experience in providing the industry with a broad range of models.
Founded in 2000, Syncrosome's staff have significant backgrounds in big pharma, academic research, mid- size pharma and biotech. Our company is proud to be part of your non-clinical strategy.
NEWS
|
Last month, Lyna Messous, In vivo technician at Syncrosome, took part to the GRRC congress in Bordeaux (France). |
Syncrosome CIR accreditation has been renewed For more than 3 years now, Syncrosome has worked as a preclinical CRO accredited by the French Ministry of Higher Education and Research |
WHERE TO MEET US
Zurich (Switzerland) from the 29th November to 1st December 2011.
Rome (Italy) the 6th &8th of December 2011.
Barcelona (Spain) from the 24th to 27th January 2012.
If you want us to visit you during these periods don't hesitate to ask us !
Independence, high level of exigence, durability
These are some of our main values. The founder is the main shareholder of the company and this fact allows us to assume our development as we wish to do it.
To ensure continuous improvement: we are regularly audited
SInce 2000, we have been audited by various companies "top ten pharma's", midsize pharma's and biotechs.
FEATURES
In routine or on demand models
You will find the description of all the models in the "" area.
You will be able to ask us for more technical datas for each of these models (log in)
Annual subscription and packages
If you are willing to outsource an important part of your non clinical projects we are available to suggest you different cost/benefit strategies to optimize your development